Mar 30, 2015 at 15:48 | Source: CNBC-TV18
CNBC-TV18's Reema Tendulkar lists out stocks that you should focus on.
Mar 30, 2015 at 15:24 | Source: PTI
Colibrium has developed a cloud-based platform that facilitates end-to-end work flow automation capability to healthcare service providers.
Mar 30, 2015 at 13:03 | Source: Moneycontrol.com
Shares of Fortis Healthcare rallied more than 5 percent intraday to hit a 52-week high of Rs 172 on Monday on divestment of complete stake in Singapore Hospital.
Mar 30, 2015 at 12:45 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, auto sector will continue receiving strong astrological support and advises buying Ashok Leyland, TVS Motor Company, Mahindra and Mahindra, Bajaj Auto, Maruti Suzuki India, Tata Motors, SML Isuzu and Hero Motocorp on every decline.
Mar 30, 2015 at 11:26 | Source: Moneycontrol.com
Decline in value of produce and profitability for the agri sector is likely to play out with a lag on agri input sectors-seeds, fertilizers and agro chemicals, says Emkay
Mar 30, 2015 at 08:47 | Source: CNBC-TV18
Here are top 10 stocks to focus on March 30 - Reliance, ONGC, IGL, Gujarat Gas, Titagarh, Concor, SpiceJet, Jet Airways, Fortis Health and Sesa Sterlite. The Research Team at CNBC-TV18 is also tracking Infosys, L&T, NCC, HCC, IRB Infra, IVRCL and Gammon Infra.
Mar 30, 2015 at 08:25 | Source: CNBC-TV18
Wipro | Grasim | ICICI Bank | GMR Infrastructure | Tata Motors | Union Bank of India | Pennar Industries | Tata Teleservices | JSPL | Fortis Healthcare | SpiceJet | Indian Hotels and Arvind are stocks, which are in the news today.
Mar 28, 2015 at 10:25 | Source: Moneycontrol.com
Cadila Healthcare has purchased 50 percent shares of Zydus BSV Pharma Private Limited (Zydus BSV) from Bharat Serums and Vaccines Limited and now Zydus BSV has become 100 percent subsidiary of Cadila Healthcare Limited.
Mar 27, 2015 at 21:15 | Source: PTI
Sofosbuvir has high potency, high barrier to resistance, pan genotypic activity, once-daily dosage, good safety profile and the limited drug-drug interactions, which makes it a breakthrough drug in Hepatitis C treatment.
Mar 27, 2015 at 17:45 | Source: PTI
The company said that J P Morgan and Religare Capital Markets acted as financial advisors to Fortis for the transaction.